| Entry |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Name | Edoxudine (USAN/INN) | ||||||||
| Formula | C11H16N2O5 | ||||||||
| Exact mass | 256.1059 | ||||||||
| Mol weight | 256.2551 | ||||||||
| Structure |  | ||||||||
| Simcomp | |||||||||
| Class | Antiviral DG02840 Anti-herpesvirus agent | ||||||||
| Remark |
| ||||||||
| Efficacy | Antiviral, DNA polymerase inhibitor | ||||||||
| Target | Herpesvirus DNA polymerase [KO:K18964] | ||||||||
| Pathway |
| ||||||||
| Structure map |
| ||||||||
| Brite | Anatomical Therapeutic Chemical (ATC) classification [BR:br08303] D DERMATOLOGICALS D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE D06B CHEMOTHERAPEUTICS FOR TOPICAL USE D06BB Antivirals D06BB09 Edoxudine D03956 Edoxudine (USAN/INN) Drug groups [BR:br08330] Antiviral DG02840 Anti-herpesvirus agent D03956 Edoxudine Antimicrobials [BR:br08307] Antivirals Genome replication inhibitor Herpesvirus DNA polymerase inhibitor D03956 Edoxudine (USAN/INN) | ||||||||
| Other DBs |
| ||||||||
| KCF data | ATOM 18 1 C1y C 39.4955 -23.1956 2 C1x C 40.8983 -23.1956 3 C1y C 41.3318 -21.8614 4 O2x O 40.1969 -21.0369 5 C1y C 39.0620 -21.8614 6 C1b C 37.7397 -21.4318 7 N4y N 42.6511 -21.4365 8 O1a O 36.6933 -22.3739 9 O1a O 38.6708 -24.3305 10 C8y C 43.7148 -22.3571 11 N4x N 45.0427 -21.9048 12 C8y C 45.3147 -20.5285 13 C8y C 44.2551 -19.6014 14 C8x C 42.9272 -20.0538 15 O5x O 43.4466 -23.7135 16 O5x O 46.6249 -20.0824 17 C1b C 44.5281 -18.2209 18 C1a C 45.8412 -17.7731 BOND 19 1 1 2 1 2 2 3 1 3 3 4 1 4 4 5 1 5 1 5 1 6 5 6 1 #Up 7 3 7 1 #Up 8 6 8 1 9 1 9 1 #Down 10 7 10 1 11 10 11 1 12 11 12 1 13 12 13 1 14 13 14 2 15 7 14 1 16 10 15 2 17 12 16 2 18 13 17 1 19 17 18 1 |